Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Banner North Colorado Medical Center - Loveland Campus and updated the Nat Med article citation with authors. Removed Banner McKee Medical Center.
    Difference
    0.1%
    Check dated 2025-12-07T23:41:25.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page.
    Difference
    0.0%
    Check dated 2025-11-30T15:39:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Publication section wording updated to indicate PubMed publications are automatically filled from PubMed, and the revision tag was updated to v3.3.1 (the corresponding deletions note updated to v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-23T14:56:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Removal of the government funding/operating status notice. The page's study details and trial information remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-16T14:43:40.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-01T07:31:33.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Summary: A version upgrade to v3.2.0 with a new operating-status notice indicating possible delays due to funding, while the previous v3.1.0 mention is removed; focus is on informing users about status and pointing to official sources.
    Difference
    1%
    Check dated 2025-10-03T08:45:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.